Results for "The Role of Distributors in the U.S. Specialty Pharmaceuticals Value Chain"
HDA Recommends a Phased Approach to Implementing the Final Requirements of the DSCSA
The Healthcare Distribution Alliance (HDA) is recommending to the Food and Drug Administration (FDA) a phased approach to final implementation of the Drug Supply Chain Security Act (DSCSA) to minimize the potential for supply disruptions and interruptions to patient care. The proposal was communicated through a recent letter to FDA.
Chip Davis Shares HDA’s 2024 Policy Priorities in Annual Chain Drug Review Column
With a presidential election on the horizon and policymakers working to develop solutions to challenges facing patients and providers, HDA’s President and CEO Chip Davis provided key insights into the association’s 2024 policy priorities in his annual column, “Health Care Outlook,” by Chain Drug Review.
HDA Statement on 2024 Presidential Election
HDA released a statement congratulating President-elect Donald J. Trump and Vice President-elect J.D. Vance on their victory in the presidential election.